Rationing in cancer treatment: is the identification of essential cytotoxic drugs feasible?
Sessa
C
C
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003365:Costs and Cost Analysis; D017048:Health Care Costs / Q000592:standards / Q000639:trends; D015276:Health Care Rationing / Q000592:standards*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics*; D013557:Switzerland; D014944:World Health Organization
D000970:Antineoplastic Agents